057: Next generation molecular diagnostics for therapy decisions and discovery for all patients with newly diagnosed glioblastoma without MGMT promotor methylation (NCT Neuro Master Match -N2M2- Diagnostics)

HIPO Investigator:

Prof. Dr. Wolfgang Wick

Prof. Dr. Andreas von Deimling

Prof. Dr. Stefan Pfister

Prof. Dr. Christel Herold-Mende

Prof. Dr. Benedikt Brors

Prof. Dr. Jürgen Debus

 

Entity: Glioblastoma

Publications:

Pfaff E et al.; Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter-hypermethylation - the NCT Neuro Master Match (N2M2) pilot study. Neuro Oncol. 2017

 

 

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009